Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05923190 |
| Title | Enfortumab Vedotin Schedule De-escalation in Metastatic Urothelial Carcinoma |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Fox Chase Cancer Center |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Fox Chase Cancer Center - Philadelphia | RECRUITING | Philadelphia | Pennsylvania | 19111-2497 | United States | Details |